Search Within

Behavioral Sciences Service

  1. "David Lebwohl"
Formats
  1. Journal Article (9)
  2. Conference Paper (3)
  3. Meeting Abstract (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (14)
  2. Breast Medicine Service (14)
  3. Department of Medicine (14)
  4. Psychiatry and Behavioral Sciences, Department of (14)
  5. Solid Tumor Oncology Division (14)
  6. Survivorship Research (14)

More Groups

People
  1. Andrew Seidman (14)
  2. Clifford Hudis (14)
  3. David Lebwohl (14)
  4. Larry Norton (14)
  5. Teresa Gilewski (14)
  6. Violante Currie (13)

More People

Years
  1. 1999 (2)
  2. 1998 (1)
  3. 1996 (3)
  4. 1995 (1)
  5. 1994 (2)
  6. 1993 (5)
Publications
  1. Journal of Clinical Oncology (4)
  2. Seminars in Oncology (3)
  3. Breast Cancer Research and Treatment (2)
  4. Annals of the New York Academy of Sciences (1)
  5. Cancer (1)
  6. Cancer Investigation (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Inc. (3)
  3. Springer (2)
  4. Informa Healthcare (1)
  5. John Wiley & Sons (1)
  6. Oxford University Press (1)

More Publishers

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study
    Journal Article

    Hudis, C.; Fornier, M.; Riccio, L.; Lebwohl, D.; Crown, J.; Gilewski, T.; Surbone, A.; Currie, V.; Seidman, A.; Reichman, B.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: Feasibility and efficacy
    Journal Article

    Hudis, C.; Seidman, A.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Moynahan, M.; Sklarin, N.; Fennelly, D.; Crown, J. P. A.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel
    Journal Article

    Hudis, C.; Riccio, L.; Seidman, A.; Baselga, J.; Currie, V.; Fennelly, D.; Gilewski, T.; Lebwohl, D.; Moynahan, M.; Raptis, G.; more...
    Cancer Investigation (1998)

    Fulltext@MSK | Save
  • Event-free survival after sequential dose-dense doxorubicin (A), paclitaxel (T) and cyclophosphamide (C) in women (pts) with ≥ 4 positive (+) axillary lymph nodes (LN)
    Meeting Abstract

    Hudis, C.; Seidman, A.; Raptis, G.; Baselga, J.; Gilewski, T.; Fennelly, D.; Lebwohl, D.; Surbone, A.; Currie, V.; Moynahan, M.; more...
    Breast Cancer Research and Treatment (1996)

    Fulltext@MSK | Save
  • Sequential adjuvant therapy: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Hudis, C.; Seidman, A.; Raptis, G.; Fennelly, D.; Gilewski, T.; Baselga, J.; Theodoulou, M.; Sklarin, N.; Moynahan, M.; Surbone, A.; more...
    Seminars in Oncology (1996)

    Fulltext@MSK | Save
  • Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer
    Journal Article

    Hudis, C. A.; Seidman, A. D.; Crown, J. P. A.; Balmaceda, C.; Freilich, R.; Gilewski, T. A.; Hakes, T. B.; Currie, V.; Lebwohl, D. E.; Baselga, J.; more...
    Journal of Clinical Oncology (1996)

    Fulltext@MSK | Save
  • Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes
    Journal Article

    Hudis, C. A.; Seidman, A. D.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Currie, V.; Moynahan, M. E.; Sklarin, N.; Fennelly, D.; more...
    Seminars in Oncology (1995)

    Fulltext@MSK | Save
  • Results of sequential dose-intensive adjuvant therapy with doxorubicin and cyclophosphamide
    Meeting Abstract

    Hudis, C.; Lebwohl, D.; Yao, T. J.; Crown, J.; Gilewski, T.; Currie, V.; Raptis, G.; Seidman, A.; Fennelly, D.; Kesselman, E.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer
    Conference Paper

    Seidman, A. D.; Norton, L.; Reichman, B. S.; Crown, J. P. A.; Yao, T. J.; Hakes, T. B.; Lebwohl, D. E.; Gilewski, T. A.; Hudis, C. A.; Surbone, A.; more...
    S. Karger AG (1994)

    Fulltext@MSK | Save
  • Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer
    Journal Article

    Reichman, B. S.; Seidman, A. D.; Crown, J. P. A.; Heelan, R.; Hakes, T. B.; Lebwohl, D. E.; Gilewski, T. A.; Surbone, A.; Currie, V.; Hudis, C. A.; more...
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save